Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis.
Lin, Ming-Wei; Suan, Dan; Lenton, Kerry; Henniker, Tony; Burke, Therese; Vucic, Steve; Fulcher, David A.
; 44(3): 248-50, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22406478
Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis.
Flow cytometric analysis of T cell/monocyte ratio in clinically isolated syndrome identifies patients at risk of rapid disease progression.
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis.
[Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome].
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.
Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event.
Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome.